1. Home
  2. AMRX

as 05-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Founded: 2002 Country:
United States
United States
Employees: N/A City: N/A
Market Cap: 2.0B IPO Year: N/A
Target Price: $8.00 AVG Volume (30 days): 1.6M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.73 EPS Growth: N/A
52 Week Low/High: $2.15 - $6.98 Next Earning Date: 05-03-2024
Revenue: $2,495,258,000 Revenue Growth: 9.82%
Revenue Growth (this year): 11.13% Revenue Growth (next year): -1.84%

Share on Social Networks: